Clinicopathologic Features and Chromosome 12p Status of Pediatric Sacrococcygeal Teratomas: A Multi-institutional Analysis.


Journal

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
ISSN: 1615-5742
Titre abrégé: Pediatr Dev Pathol
Pays: United States
ID NLM: 9809673

Informations de publication

Date de publication:
Historique:
pubmed: 5 9 2018
medline: 10 9 2019
entrez: 5 9 2018
Statut: ppublish

Résumé

Chromosome 12p gains are typically present in postpubertal male patients with testicular malignant germ cell tumors, including most teratomas, and absent in pure ovarian teratomas, both mature and immature. We sought to evaluate the clinicopathologic features and chromosome 12p status of pediatric patients with sacrococcygeal teratomas (SCTs) using the institutional databases of 2 tertiary medical centers. Seven mature teratomas (3 pure, 2 with yolk sac tumor, 1 with medulloepithelioma, and 1 with ependymoma) and 3 immature teratomas (2 pure: grade 2 and grade 3 and 1 mixed: grade 3 with yolk sac tumor) were identified. All patients underwent surgery and 2 received adjuvant chemotherapy. Fluorescence in situ hybridization analysis was performed to elucidate chromosome 12p gains, including isochromosome 12p. All 10 tumors analyzed lacked 12p gains regardless of the components. No patient had evidence of disease at their most recent interval follow-up (mean: 30, range: 7-91 months), irrespective of margin status or of receiving chemotherapy. Overall, our study suggests an absence of chromosome 12p abnormalities in clinically nonaggressive SCTs. Additional data are required to confirm these findings before definitive patient care recommendations can be made.

Identifiants

pubmed: 30176765
doi: 10.1177/1093526618798771
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

214-220

Auteurs

Konstantinos S Mylonas (KS)

1 Department of Pediatric Surgery, Massachusetts General Hospital, Boston, Massachusetts.

Chia-Sui Kao (CS)

2 Department of Pathology, Stanford University School of Medicine, Stanford, California.

David Levy (D)

2 Department of Pathology, Stanford University School of Medicine, Stanford, California.

Leonardo Lordello (L)

3 Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts.

Paola Dal Cin (P)

4 Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.

Peter T Masiakos (PT)

1 Department of Pediatric Surgery, Massachusetts General Hospital, Boston, Massachusetts.

Esther Oliva (E)

3 Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH